ALLOCATE – Acquired immunologicaL LOw prevalence and Complex AdulT diseases of thE SKIN
Thematic group
Chairs and Focus
Related Conditions
Participating Reference Centres
- APHP – Hôpital Necker-Enfants malades
- ASL Tuscan Centre
- Cardiff and Vale University Health Board
- Cliniques Universitaires de Bruxelles – Hôpital Erasme
- Erasmus MC: University Medical Center Rotterdam
- Fondazione Policlinico Universitario A. Gemelli – Roma
- Hospital of Lithuanian University of Health Sciences Kauno Klinikos
- Odense University Hospital
- Städtisches Klinikum Dessau
- Szent-Györgyi Albert Medical Center, University of Szeged
- The Leeds Teaching Hospitals NHS Trust
- Universitätsklinikum Würzburg
- University Hospital Centre Zagreb
- University Hospital Královské Vinohrady
- University Medical Center Utrecht – Rotterdam
- University of Debrecen
- Zealand University Hospital
Dashboard
Legend for guidelines and publications
Clinical Outcome Measures
No public document yet
Emergency Cards
No public document yet
Clinical Decision Support Tools
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement- Global consensus process to establish a core data set for hidradenitis suppurativa registries
- Viewpoint on the evaluation of severity and treatment effects in mild hidradenitis suppurativa: the cumulative IHS4 (IHS4-C)
Guidelines & Recommendations
- S2k guideline for the treatment of hidradenitis suppurativa/acne inversa
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines- Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group
- Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4)
- European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Patient Documents
Publications
- Overview and comparison of the clinical scores in hidradenitis suppurativa: A real-life clinical data
- Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa
- External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort
- What causes hidradenitis suppurativa ?-15 years after
- Metascoring Hidradenitis suppurativa
- Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis
Training
No public document yet